Published in
American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 5(66), 2022
DOI: 10.1128/aac.02319-21
Links
Tools
Preclinical Data on the Gardnerella -Specific Endolysin PM-477 Indicate Its Potential to Improve the Treatment of Bacterial Vaginosis through Enhanced Biofilm Removal and Avoidance of Resistance
Journal article published in 2022 by
Christine Landlinger 
,
Vera Oberbauer ,
Lenka Podpera Tisakova ,
Timo Schwebs,
Rocío Berdaguer,
Leen Van Simaey,
Mario Vaneechoutte ,
Lorenzo Corsini
,
Vera Oberbauer ,
Lenka Podpera Tisakova ,
Timo Schwebs,
Rocío Berdaguer,
Leen Van Simaey,
Mario Vaneechoutte ,
Lorenzo Corsini
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Antibiotics are the mainstay of therapy for bacterial vaginosis (BV). However, the rate of treatment failure in patients with recurrent BV is about 50%.